Physician profile
David Haddad
NPI 1104445097
$25,902.96
in general payments reported to CMS, 2019-2025
30 companies · $8,794 in 2025
The $8,794 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,408 · 2021: $4,306 · 2022: $4,723 · 2023: $4,612 · 2024: $2,061 · 2025: $8,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,351 · Consulting Fee: $6,100 · Travel and Lodging: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,351.10 |
| Consulting Fee | $6,100.00 |
| Travel and Lodging | $2,015.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,829.81 | 2020-2025 | Augment Injectable, Prostep, Salvation |
| Lifenet Health | $6,745.92 | 2024-2025 | Theragenesis Wound Matrix |
| Arthrex, INC. | $3,656.12 | 2021-2023 | |
| Pylant Medical | $2,628.77 | 2022-2025 | |
| Liberty Surgical INC. | $1,267.63 | 2020 | |
| Organogenesis INC. | $620.77 | 2020-2025 | Affinity, Cygnus Dual |
| Treace Medical Concepts, INC. | $466.21 | 2021-2025 | |
| Kerecis Limited | $405.10 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Nevro Corp. | $308.88 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $241.26 | 2021-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $216.28 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $168.15 | 2021 | |
| Omeza LLC | $163.97 | 2023 | |
| Biotissue Holdings INC. | $152.57 | 2023 | |
| Globus Medical, INC. | $147.54 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $124.91 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $115.27 | 2022 | |
| Medical Device Business Services, INC. | $102.80 | 2024 | |
| Seapearl East, INC | $99.00 | 2021 | |
| Depuy Synthes Sales INC. | $82.75 | 2022-2024 | Na, Hammerlock, Va-Lcp |
| Convatec INC. | $79.92 | 2023-2024 | |
| Foundation Fusion Solutions, LLC | $71.94 | 2024 | |
| Paratek Pharmaceuticals, INC. | $62.45 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $30.53 | 2023-2024 | Renasys Touch, Renasys Go V2 Home, Pico 7 |
| Averitas Pharma INC. | $29.98 | 2024 | Qutenza |
| Davol INC. | $20.65 | 2023 | Arista Ah Flexitip |
| Avita Medical Americas, LLC | $19.46 | 2025 | Cohealyx, Permeaderm, Recell |
| Musculoskeletal Transplant Foundation INC. | $17.02 | 2023 | |
| Amgen INC. | $14.10 | 2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.